USP9YP3

Across TCGA pan-cancer cohorts, USP9YP3 RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated USP9YP3 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher USP9YP3 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated USP9YP3 expression acts as an unfavorable survival marker, although some lineages such as HNSC show a favorable association.

LUAD, LIHC, and UCEC are the cancer types where USP9YP3 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Tertile	All	0.590	0.820	<.001	138	view →
LIHC	DFS	Tertile	II,III,IV	0.080	0.423	<.001	63	view →
UCEC	OS	Tertile	All	0.344	0.680	.004	42	view →
ESCA	OS	Tertile	IV	0.095	0.512	.008	36	view →
KIRP	DFS	Tertile	All	0.384	0.628	<.001	33	view →
BLCA	DFS	Tertile	All	0.450	0.634	.023	18	view →
THCA	DFS	Tertile	All	0.827	0.936	.025	9	view →
HNSC	OS	Tertile	III,IV	0.818	0.314	.041	3	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

USP9YP3–LUAD (OS)

Open the LUAD breakdown →